BioSpace News Archive

The study will look into the effects of Fortetropin on increasing the fractional rate of skeletal muscle protein synthesis in men and women between 60 and 75 years old.

At NovaBay, he will be responsible for leading all commercial activities, including driving sales and revenue growth of Avenova in new and existing markets, and expanding the Company’s global commercial channel.

Most recently, Mr. Cooper was the CFO of Receptos from 2013 until its sale in 2015 to Celgene for $7.8B.

Vestagen today announced that the protective properties of VESTEX will be discussed in two scientific presentations at the upcoming IHI 2017 National Forum on Quality Improvement in Health Care conference being held December 10-13 in Orlando, FL.

Generational Equity is pleased to announce a majority acquisition of its client, LGM Pharma, by New Harbor Capital LLC.

Meda Aktiebolag has successfully amended the terms and conditions of two series of notes issued pursuant to its SEK 7,000,000,000 medium term notes programme and inserted an early redemption call option which it will exercise with immediate effect

The data presented is expected to demonstrate the potential for CGP to improve disease classification, to offer personalized prognostic information and to support therapeutic treatment decision making by informing treating physicians about the use of novel treatment options, including cancer immunotherapies.

Results showed these trastuzumab-ICOSL “V-mAbs” promoted T cell proliferation and cytokine secretion and enhanced killing of tumor cells.

These data, presented at the 22nd biennial HEP DART meeting held in Kona, Hawaii, from Dec. 3-7, indicate that multiple doses of an RNAi-based therapy may lead to a host response that is sustained after therapy is concluded.

An option for an agreement extension will be evaluated, considered and negotiated by Tersus and Relevium, subject to the fulfillment of the two (2) year Agreement Terms.